Both companies have built extensive patent thickets around their core molecules, with Novo Nordisk in particular pursuing aggressive filing strategies across new formulations, indications, and delivery methods
Compare compound profiles Use this Avion tool to keep researchers moving through the website instead of leaving after one article
These include GLP-1, GIP, peptide YY, and cholecystokinin (CCK), among others
On average, participants lost 15.1% of their body weight after 68 weeks compared to 2.4% of body weight from those on the placebo
In another study, intraperitoneal administration of BPC-157 (2ug/kg) improved motor function, reduced lesions in white and grey matter and relieved neuronal damage in rats with spinal cord injury [5] Research in the alkali burn rat models has shown that topical BPC-157 can speed up wound closure